Lifecare ASA is a Norway-based company that develops miniaturized and implantable nanobiosensors for correct and continuous monitoring of glucose and other biomarkers. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.

Employees

Sector

Biotechnology & Medical Research

Calendar

12/11 Earnings release - Q3 2026

More about the company

Quotes

Date	Price	Change	Volume
20/26/20	NOK 0.2880	-5.57%	21,73,636
19/26/19	NOK 0.3050	-3.79%	1,54,95,546
18/26/18	NOK 0.3170	+0.63%	13,25,809
17/26/17	NOK 0.3150	-0.94%	7,68,124
14/26/14	NOK 0.3180	-0.63%	8,76,442

Real-time Oslo Bors

More quotes

EPS Estimates

Revisions to estimates

Annual profits - Rate of surprise

Company calendar

Market Closed - Oslo Bors 08:15:00 20/08/2026 pm IST			5-day change	1st Jan Change
0.2880 ^NOK	-5.57%		-10.00%	-91.17%

19/08	Lifecare ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
19/08	Lifecare ASA, Q2 2026 Earnings Call, Aug 19, 2026

Market Cap	9.09Cr 97.35L 83.35L 77.77L 71.36L 1.34Cr 93Cr 1.37Cr 9.23Cr 3.6Cr 47Cr 3.66Cr 3.58Cr 154.55Cr	P/E 2026 *	-0.87x	P/E 2027 *	-1.91x
Enterprise Value	8.19Cr 87.72L 75.1L 70.07L 64.3L 1.21Cr 84Cr 1.23Cr 8.31Cr 3.24Cr 42Cr 3.29Cr 3.22Cr 139.26Cr	EV / Sales 2026 *	81.9x	EV / Sales 2027 *	-
Free-Float	89.66%	Yield 2026 *	-	Yield 2027 *	-

19/08	Lifecare ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
19/08	Lifecare ASA, Q2 2026 Earnings Call, Aug 19, 2026
02/07	Lifecare Completes Production Transfer and Provides Update on Longevity Programme	CI
29/06	Lifecare Transfers Operations from Germany to Norway, UK	MT
27/06	Lifecare ASA Discontinues Operations of Lifecare Germany GmbH	CI
10/06	Lifecare Completes First Six-Month Implant Evaluation With Continued Functionality and No Adverse Biological Response	CI
15/05	Lifecare ASA, Q1 2026 Earnings Call, May 15, 2026
15/05	Lifecare ASA Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
15/05	Lifecare Q1 operating loss NOK 31.5 mln	RE
23/04	Lifecare ASA Approves Board Appointments	CI
27/03	Lifecare ASA Announces Operational Restructuring And Centralization Of Operations	CI
27/03	Lifecare ASA Announces Discontinuation of the Business Operations of Lifecare Germany GmbH	CI
26/03	Lifecare ASA to Close German Operations, Consolidate Activities Under Planned Centralization	MT

19/08	Lifecare : Interim Report Q2 2026 Presentation	PU
19/08	LIFE: Lifecare ASA Q2 2026 results	PU
12/08	Lifecare ASA (LIFE): Invitation to presentation of Q2 2026 results 19 August at 08.45 CEST	AQ
02/07	LIFE: Update on production transfer and longevity programme	AQ
26/06	LIFE: Operational update regarding Lifecare Germany GmbH (i.L)	PU

Lifecare ASA Share Price

Stocks

LIFE

NO0013355859

Biotechnology & Medical Research

Valuation: Lifecare ASA

Chart: Lifecare ASA

Latest news : Lifecare ASA

Last Transcript: Lifecare ASA

Analysts' recommendations: Lifecare ASA

Press Releases: Lifecare ASA

News in other languages: Lifecare ASA

Quotes and Performance

Course Extremes

Managers and Directors: Lifecare ASA

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

1 day	-5.57%
1 week	-10.00%
Current month	-13.25%
1 month	-4.00%
3 months	-22.89%
6 months	-29.24%
Current year	-91.17%

1 week	0.29	0.36
1 month	0.28	0.38
Current year	0.27	1.99
1 year	0.27	14.7
3 years	0.27	82.16
5 years	0.27	82.16
10 years	0.27	117

Manager	Title	Age	Since
Joacim Holter CEO	Chief Executive Officer	50	07/09/2020
Petter Nielsen DFI	Director of Finance/CFO	-	01/04/2026
Torsten Ernst PRN	Corporate Officer/Principal	-	01/03/2024

Director	Title	Age	Since
Trine Teigland BRD	Director/Board Member	-	26/06/2020
Morten Foros Krohnstad CHM	Chairman	-	08/05/2021
Lutz Heinemann BRD	Director/Board Member	-	20/11/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LIFECARE ASA	-5.57%	-10.00%	-97.51%	-98.89%	97.39L
LONZA GROUP AG	+1.14%	+2.27%	+2.38%	+24.66%	5.05TCr
REVOLUTION MEDICINES, INC.	-0.91%	+4.38%	+483.10%	+605.89%	4.6TCr
BEONE MEDICINES AG	-1.29%	+4.61%	+20.40%	+89.89%	4.28TCr
IQVIA HOLDINGS INC.	+3.93%	+7.09%	+34.68%	+20.66%	4.1TCr
CELLTRION, INC.	0.00%	-3.91%	+17.87%	+47.98%	3.2TCr
MEDPACE HOLDINGS, INC.	+1.28%	+5.78%	+32.18%	+150.26%	1.7TCr
ASCENDIS PHARMA A/S	-0.88%	+4.08%	-	-	1.71TCr
EUROFINS SCIENTIFIC SE	+3.06%	+3.88%	+5.81%	+35.45%	1.43TCr
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+1.85%	+5.51%	+85.98%	+47.72%	1.38TCr
Average	+0.31%	+1.37%	+64.99%	+102.62%	2.75TCr
Weighted average by Cap.	+0.78%	+2.37%	+104.97%	+151.72%

	2026 *	2027 *
Net sales	10L 1L 91.67T 85.53T 78.48T 1L 1.02Cr 2L 10.15L 4L 51.34L 4L 4L 1.7Cr	-
Net income	-11Cr -1.17Cr -99.92L -93.23L -85.55L -1.61Cr -111.67Cr -1.64Cr -11Cr -4.31Cr -56Cr -4.38Cr -4.29Cr -185.28Cr	-6.7Cr -71.74L -61.42L -57.31L -52.58L -98.81L -69Cr -1.01Cr -6.8Cr -2.65Cr -34Cr -2.69Cr -2.63Cr -113.88Cr
Net Debt	-90L -10L -8L -8L -7L -13.27L -9.22Cr -13.53L -91.32L -35.6L -4.62Cr -36.18L -35.39L -15Cr	40L 4L 4L 3L 3L 6L 4.1Cr 6L 40.59L 15.82L 2.05Cr 16.08L 15.73L 6.8Cr